Delayed access and provision of dermatological care as a collateral damage of COVID-19-related fear: Allergic contact dermatitis to fluconazole

First-line therapy for both topical and systemic mycosis includes azoles. Despite their widespread use, they rarely cause cutaneous allergic reactions.1 We present a patient with allergic contact dermati- tis localized on the feet and around the toenails, who experienced a generalized cutaneous reaction secondary to oral fluconazole, in whom a prompter dermatological visit would have anticipated the cor- rect diagnosis.